Skip to main content
. 2024 Jun 27;13(7):775. doi: 10.3390/antiox13070775
ACPA anti-citrullinated peptide/protein antibodies
ACR American College of Rheumatology
ADA anti-drug antibodies
AIA adjuvant-induced arthritis
AIF apoptosis-inducing factor
AKBA acetyl keto boswellic acid
AKT AKT serine/threonine kinase
AMPK 5′-AMP-activated protein kinase catalytic subunit alpha-1
AP-1 adaptor protein 1
APC antigen-presenting cell
ARE antioxidative response element
BAX apoptosis regulator BAX
BCL-2 apoptosis regulator Bcl-2
Breg B regulatory cells
CA curculigoside A
CAT catalase
CBD cannabidiol
CCL-1 monocyte chemoattractant protein-1
CCR6 chemokine receptor 6
CDAI Clinical Disease Activity Index
CIA collagen-induced arthritis
COX cyclooxygenase
CRP C-reactive protein
CTLA4 cytotoxic T-lymphocyte-associated protein 4
CYP cytochrome P450
DAS Disease Activity Score
DMARDs disease-modifying antirheumatic drugs
EGCG epigallocatechin gallate
EGFR epidermal growth factor receptor
ERK extracellular signal-regulated kinase
ESR erythrocyte sedimentation rate
EULAR European League Against Rheumatism
FGFR fibroblast growth factor receptor 1
FLS fibroblast-like synoviocytes
GCQG glucosamine-chondroitin-quercetin glucoside
GPX glutathione peroxidase
GSH glutathione
GWAS genome-wide association studies
HAQ-DI Health Assessment Questionnaire Disability Index
HLA human leukocyte antigen
HO-1 heme oxygenase-1
HOMA-IR Homeostatic Model Assessment of Insulin Resistance
ICAM-1 intercellular adhesion molecule 1
IL interleukin
IL-23R interleukin-23 receptor
INF-γ interferon-γ
iNOS inducible nitric oxide synthase
IRF5 interferon regulatory factor 5
IκBα NF-kappa-B inhibitor alpha
JAK Janus kinase
LPO lipid peroxidase
LPS lipopolysaccharide
MAPK mitogen-activated protein kinase
MCL-1 myeloid cell leukemia 1
MDA malondialdehyde
M-EC membrane-camouflaged nanoparticles
MEK1 dual specificity mitogen-activated protein kinase kinase 1
MMP matrix metalloproteinase
mPGES-1 microsomal prostaglandin E2 synthase-1
MPO myeloperoxidase
MRQ Maharasnadhi quathar
MTX methotrexate
NFATc1 nuclear factor of activated T cells 1
NF-κB nuclear factor kappa B
NO nitric oxide
NOEL no observed effect level
NPRS Numeric Pain Rating Scale
NRF-2 nuclear factor erythroid 2-related factor 2
NSAIDs nonsteroidal anti-inflammatory drugs
OA osteoarthritis
PADI4 protein-arginine deiminase type-4
PARP-1 poly ADPribose polymerase
PBS phosphate buffered saline
PGE-2 prostaglandin E2
PI3K phosphatidylinositol 4,5-bisphosphate 3-kinase
PKC protein kinase C
PROs patient-reported outcomes
PTPN22 phosphatase non-receptor type 22
RA rheumatoid arthritis
RANKL receptor activator for nuclear factor κB ligand
RBA roburic acid
RF rheumatoid factor
RNS reactive nitrogen species
ROS reactive oxygen species
SE shared epitope
SIRT1 sirtuin 1
SJC swollen joint count
SOD superoxide dismutase
STAT signal transducer and activator of transcription
TBARS thiobarbituric acid reacting substances
TGF-β transforming growth factor β
THC tetrahydrocannabinol
TJC tender joint count
TNF-R1 tumor necrosis factor receptor 1
TNF-α tumor necrosis factor-alpha
TRAF1/6 TNF receptor-associated factor 1/6
Tregs regulatory T cells
UT Uncaria tomentosa
VAS Visual Analog Scale
VCAM-1 vascular cell adhesion protein 1
VEGF vascular endothelial growth factor
VEGFR vascular endothelial growth factor receptor
WC Weldehi choornaya
WOMAC Western Ontario and McMaster Universities Osteoarthritis Index